Legacy Financial Group (Iowa)’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-13
Closed -$531 91
2023
Q3
$531 Buy
+13
New +$531 ﹤0.01% 538